Navigation Links
Cypher Sirolimus-eluting Coronary Stent

ProductsCypher Sirolimus-eluting Coronary Stent
Company Cordis Corporation
Item Cypher Sirolimus-eluting Coronary Stent
Features Remarkable Safety
  • The CYPHER Stent has proven to be safe and effective in the largest number of drug-eluting stent clinical trials involving the most patients, over the longest period of time.
Lasting Efficacy
  • The CYPHER Stent has shown to significantly reduce late loss and target lesion revascularization (TLR), even in the most challenging trials to date.
Description The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, sirolimus elutes into the vessel wall and impedes the process of neointimal hyperplasia, thereby significantly reducing the incidence of in-stent restenosis.
Info Cordis Corporation
Customer Service: (800) 327-7714
Web site: http://www.cordis.com/

Related medicine products :

1. Cypher Stent
2. Atlantis SR Pro Coronary Imaging Catheter
3. MULTI-LINK OTW PIXEL Coronary Stent System
4. MULTI-LINK RX PIXEL Coronary Stent System
5. Express Coronary Stent System
6. S660 with Discrete Technology Coronary Stent System
7. MULTI-LINK OTW ZETA Coronary Stent System
8. MULTI-LINK OTW PENTA Coronary Stent System
9. MULTI-LINK RX PENTA Coronary Stent System
10. MULTI-LINK RX ZETA Coronary Stent System
11. MULTI-LINK OTW ULTRA Coronary Stent System
Surgitie&trade Single Use Ligating Loops with Delivery System...
Surgitie&trade Single Use Ligating Loops with Delivery System...
ENDO STITCH&trade Triple-Stitch Single Use Loading Units for use with ENDO Stitch* 10 mm Suturing Device....
ENDO STITCH™ Single Use Loading Units....
Medicine Products:
(Date:5/31/2016)... ... 2016 , ... Psoriasis: Targets and Therapy has ... corresponding author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy ... the onset and the severity of psoriasis, and negatively influences the response to ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... calls back to particular advertising campaigns, to monitor the performance of sales and ... can maximize conversions and revenue. The software allows customers to record, transcribe, route, ...
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the multiple awards ... is home to Ontario’s leading day spa and one of Canada’s few accredited 5 ... a unique concept to combine spa services with hair and beauty services ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 According ... Biometrics Market by Technology (Single-factor (Fingerprint, Face, ... Application (Workforce Management), End User (Hospitals, Healthcare ... by MarketsandMarkets, the market is projected to ... USD 1,182.6 Million by 2016, at a ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
(Date:5/27/2016)... LabStyle Innovations Corp . ( ... today announced that the Company,s Chief Financial Officer, Zvi ... held June 1-2 in New York, NY ... in Los Angeles, CA. ... operational milestones, including the U.S. FDA Clearance and commercial launch ...
Breaking Medicine Technology: